A psychedelic medication is a psychoactive drug, capable of modifying an individual’s awareness and vision. The idea that a recreational drug may induce the development of mental illness in an abuser has long been a matter of debate. Psychiatrists are, in general, prejudiced against the use of psychedelic drugs and blames their use for causing mental disorder and developing suicidal tendencies. However there is no link between psychedelic drug use and mental illness, according to a new study. If you wish to learn more about this, visit Psilocybin Canada .
The authors of the study claim that the potential harms correlated with these medications are insignificant and do not cause addiction or compulsive use by psychedelic drugs. This notes the recreational medications are only connected to 0.005 per cent of emergency department admissions in the United States. Even in places like the Netherlands, where psilocybin (a psychedelic drug) mushrooms are widely available and used, the levels of serious drug-related injuries are quite small, according to the study.
The study conducted by Johansen and Krebs used the annual statistics from the National Survey on Drug Use and Health (NSDUH), which compiles estimates relating to drug use and mental health from a random sample reflecting the non-institutionalized civilian population in the United States. The study compiled data from survey years 2008-2011 from respondents who were 18 years of age and higher.
The scientists analyzed a survey of 135,095 respondents using LSD, psilocybin, mescaline, or peyote, of which 19,299 confirmed lifelong use of a psychedelic drug. All these were typical serotonergic instances with psychedelics. The writers also analyzed 11 self-reported markers of mental health problems from the previous year, including stress, anxiety disorders, and suicidal thoughts, intentions, and attempts.
It has been observed that the psychedelic users are younger, male, caucasian, single, vulnerable to risky activities, and have used other drugs. We are even vulnerable to disclose depression before age 18. Depression in adolescents, the researchers felt, might be the explanation why respondents sought psychedelic drugs. The study found there was no related lifelong use of experimental drugs with any mental health issues. The lifelong psychedelic use, on the opposite, was correlated with a lower likelihood of inpatient mental health care in them from last year.
But those with severe drug misuse issues need to go for rehab, as its long-term dependence negative impacts are comparable to any other addictive product. Anyone searching for treatment centers for drug addiction can choose from a host of treatment centers that are scattered across the state.
The report dismissed a few misconceptions from the past and confirmed that psychedelic drugs do not actually cause mental illness. For instance, the use of psychedelic drugs by users was correlated with “flashbacks” in the past, particularly in the sixties. But the writers said that schizophrenia was usually assigned among patients who supposedly had so-called nightmares, and they were still fascinated about their drug experience.